About ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) On October 6, 2017, ZILRETTA was approved by the U.S. Food and Drug Administration as the first and only ...

Other revenue, including sales of bupivacaine liposome injectable suspension and royalties ... ZILRETTA employs proprietary microsphere technology combining triamcinolone acetonide—a commonly ...

Other revenue, including sales of bupivacaine liposome injectable suspension and royalties ... ZILRETTA is contraindicated in patients who are hypersensitive to triamcinolone acetonide, ...

Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...

The patients in our study found our triamcinolone acetonide mouthwash to be particularly convenient to use, but it was reported to be too sweet.

Aristada comes as a liquid solution. It’s given as an injection into a shoulder or buttock muscle by a healthcare professional in an outpatient facility. You will not inject this medication ...

NASHVILLE, Tenn., January 07, 2025--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Amir H. Shojaei, PharmD, PhD, has joined Harrow as Chief ...

eyecenter.ucsd.edu or chenhao{at}mail.eye.ac.cn Aim To characterise the pharmacokinetics of triamcinolone acetonide (TA) in various ocular tissues following a single sub-Tenon injection. Methods ...